A look at risk-based monitoring, 12 months later
The implementation of risk-based monitoring is moving forward, but it is not without its challenges
3rd September 2018
Thought Leadership
Napp: leading the way in the biosimilars era
The hard work to support the NHS in adopting biosimilars is not yet complete
3rd September 2018
The rate of lung cancer in young women is now higher than in men
New study reveals lung cancer rates are now higher in young American women than men
29th August 2018
Immune checkpoint inhibitors – why they matter in today's cancer research
Cancer research hinges on developing improved methods to effectively lyse cancer cells. This is where immune checkpoint inhibitors come into direct focus
22nd August 2018
Do we really know our customers?
Why patient centricity throughout the lifecycle is not a fad, sales tactic or trend
17th July 2018
Unlocking potential: How can pharma capitalise on its resources to support the NHS?
Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online
16th July 2018
Tackling pharma’s predatory research problem
Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences
12th July 2018
Working together: the 3rd Annual Patient Engagement and Experience Conference
The importance of a patient-centric focus to improve the real-world use of medicine was extensively discussed during the 3rd Annual Patient Engagement and Experience Conference (16–17th May 2018, Amsterdam, Netherlands).
27th June 2018
Beyond the PBM - a new order for healthcare delivery - DRG
The ongoing migration of healthcare currency, from volume to value, is reshaping the healthcare ecosystem. A recent spate of vertical integration, the arrival of new players and partnerships, and the reinvention of the PBMs, continue to disrupt and transform the healthcare value chain
15th May 2018
